This study, sponsored by Region Örebro County, aims to establish ddPCR as a diagnostic tool for assessing bacterial load and treatment efficacy in septic patients. Given the high mortality rates associated with sepsis and the challenges in timely diagnosis and treatment, successful validation of this method could address significant unmet medical needs in critical care. The findings may enhance antibiotic stewardship and reduce the incidence of antibiotic resistance, positioning ddPCR as a valuable asset in the sepsis management market. The potential for commercialization hinges on demonstrating clinical utility and integration into existing diagnostic workflows, which could attract interest from diagnostic companies and pharmaceutical partners.